Global Advanced Dermatology Drug Delivery Devices Market

Report ID : 1235 | Published : 2022-09-26 | Pages: 180 | Format: PDF/EXCEL

The Global Advanced Dermatology Drug Delivery Devices Market is estimated to reach over USD 9.60 Billion by 2030, exhibiting a CAGR of 9.4% during the forecast period. 

Drug delivery through the skin is not a new concept; needle-and-syringe combinations have been utilized for decades. Drug delivery with extra features for reduced pain, improved medication adherence, customer interaction, user-friendly design, and convenience of administration are all part of the advanced dermatology drug delivery device concept. Among the devices available are injectors, patches, airless dispensers and bottles, dermal pumps, valves, and add-on devices for safety and better connectivity. Furthermore, the sector is being led by an increase in the use of connected devices, a growth in the number of business synergies with pharmaceutical businesses, and an increasing focus on prescription/medication adherence. Furthermore, as consumers' preferences shift toward connected devices, proprietary technologies are expected to become increasingly important differentiators for both new entrants and established organizations in the future. Furthermore, the industry is expected to grow as protocols become more common and people become more aware of the benefits of connected devices. Stringent restrictions and concerns about data privacy, as well as a lack of awareness about modern dermatology drug delivery devices among a broad segment of the public in emerging nations, are limiting the market's growth. Connected healthcare is a game-changing notion. However, it raises worries about data privacy. Networked medical equipment, like other linked devices, are vulnerable to security breaches. The market experienced a strong rate of innovation in terms of new introductions during the period 2015-2020. Furthermore, the concept of connected medical devices is a relatively new concept that will take time to gain traction among the general public, particularly in emerging markets.

Market Segmentation:

The Advanced Dermatology Drug Delivery Devices Market is segmented on the basis of Market by Products, Market by Sales Channel, and Market by End-Users. Based on Products, the market is segmented as Injectors, Disposable Injectors, Reusable Injectors, Wearable Injectors, Patches, Microneedle Patches, Solid Removable Microneedles, Coated Microneedles, Dissolving Microneedles, Hollow Microneedles, Hydrogel Forming Microneedles, Needle-Less Patches, Dermal Pumps, Airless Dispensers and Bottles, Valves, and Other Devices. By Sales Channel, the market is segmented into    B2B Sales Channel, and B2C Sales Channel. By End-Users, the market is segmented into Hospitals, Dermatology Practices, and Home Use.

Based on product, the Injectors segment is accounted as a major contributor in the Advanced Dermatology Drug Delivery Devices Market 

In 2021, injectors had the majority of the market share in the global advanced dermatological drug delivery devices market. Several innovations in product design and user involvement are boosting the injectors industry. Self-administration is also possible using injectors and autoinjectors. As a result, the convenience of use of an injector, product, or brand is essential for the performance. Furthermore, patient surveys were undertaken to identify the top factors that influence physician and patient preferences, such as comfortable grip and ease of self-injection. Some of the main companies' product specifications and unique selling points (USPs) demonstrate a great effort to ensure optimized simplicity of use while also delivering customized offers. Customization options are frequently provided for criteria including the kind of formulation, dosage, and dosage schedule. Consumer convenience is also at the forefront of innovation in the devices now under development.

Hospitals segment witness growth at a rapid rate.

Hospitals, dermatological practices, and home use are all part of the global advanced dermatology drug delivery devices market by end user. The global advanced dermatology delivery devices market's key end customers are hospitals. For immunization purposes, the use of these devices in hospitals and dermatology practices (clinics) has been steadily rising. Furthermore, the COVID-19 epidemic has aided in the acceleration of demand for connected and home-use gadgets. The segment's rise is also being fueled by developments in drug delivery technologies that promote adherence.

In the region, the North America Advanced Dermatology Drug Delivery Devices Market holds significant revenue share.

The global market for advanced dermatology drug delivery devices is expected to grow at a considerable CAGR in North America. The healthcare systems in North America are among the most technologically advanced in the world. The region boasts a considerable number of early adopters for advanced dermatology medication delivery systems, and it is the world's top market for these devices. However, Europe is the fastest-growing region during the forecast period. Europe is a crucial market for early adopters of innovative devices, and it is projected to be one of the top markets for sophisticated dermatology drug delivery systems in the future. Connected devices have grown in popularity in Europe due to the benefits they offer over traditional techniques including enhanced patient care and safety, shorter hospital stays, and faster recovery. Furthermore, the European Union is a world leader in terms of design, features, and technology. Strategic collaborations, M&As, and a strong preference for innovative medication delivery systems among end-users are projected to help the European industry. 

Competitive Landscape

AptarGroup, Inc., Becton, Dickinson and Company, Bespak, Credence MedSystems, Inc., E3D Elcam Drug Delivery Devices, Kindeva Drug Delivery L.P., Latch Medical, LTS Lohmann Therapie-Systeme AG, Medicsensors S.L, Midas Pharma GmbH, Nemera, Owen Mumford, Portal Instruments, Inc., Vaxxas Inc., West Pharmaceutical Services, Inc., The 3M Company, Zosano Pharma Corporation, Raphas Co., Ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microdermics Inc., TheraJect, Inc., Endoderma Ltd., QuadMedicine, SNvia Co., Ltd., Small Lab, AdminMed nanoBioSciences LLC, BioSerenTach Inc, Innoture Medical, Technology Limited, Clearside Biomedical, CosMED Pharmaceutical Co.Ltd., Mindera Corp, and List of Other Prominent Players are some of the major players in the market In the last few years, the global advanced dermatology drug delivery devices market has seen significant strategic and technological developments performed by several industry players in order to achieve their respective market shares in this expanding area. Funding activities, mergers and acquisitions (M&A), partnerships, alliances, and company expansion, regulatory and legal operations, and new offers are some of the tactics covered in this area.  Business synergies have been the preferred method for companies, followed by finance activities.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Advanced Dermatology Drug Delivery Devices Market Snapshot

Chapter 4. Global Advanced Dermatology Drug Delivery Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Key Trends in the Market

4.8. COVID 19 Impact Analysis

Chapter 5. Advanced Dermatology Drug Delivery Devices Market Segmentation 1: By Types Estimates & Trend Analysis

5.1. By Products & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

5.2.1. Injectors

5.2.1.1.  Disposable Injectors

5.2.1.2.  Reusable Injectors

5.2.1.3.  Wearable Injectors

5.2.2. Patches

5.2.2.1.  Microneedle Patches (MNPs)

5.2.2.1.1.   Solid Removable Microneedles

5.2.2.1.2.   Coated Microneedles

5.2.2.1.3.   Dissolving Microneedles

5.2.2.1.4.   Hollow Microneedles

5.2.2.1.5.   Hydrogel Forming Microneedles

5.2.2.1.6.  Needle-Less Patches

5.2.3. Airless Dispensers and Bottles

5.2.4. Dermal Pumps

5.2.5. Valves

5.2.6. Other Devices

Chapter 6. Advanced Dermatology Drug Delivery Devices Market Segmentation 2: By Sales Channel Estimates & Trend Analysis

6.1. By Sales Channel & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Sales Channel:

6.2.1. B2B Sales Channel

6.2.2. B2C Sales Channel

Chapter 7. Advanced Dermatology Drug Delivery Devices Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By End-Users Analysis & Market Share, 2020 & 2030

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

7.2.1. Hospitals

7.2.2. Dermatology Practices

7.2.3. Home Use

Chapter 8. Advanced Dermatology Drug Delivery Devices Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.1.2. North America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sales Channel, 2020-2030

8.1.3. North America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.1.4. North America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.2.2. Europe Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sales Channel, 2020-2030

8.2.3. Europe Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.2.4. Europe Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.3.2. Asia Pacific Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sales Channel, 2020-2030

8.3.3. Asia Pacific Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.3.4. Asia Pacific Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.4.2. Latin America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sales Channel, 2020-2030

8.4.3. Latin America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.4.4. Latin America Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2020-2030

8.5.2. MEA Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Sales Channel, 2020-2030

8.5.3. MEA revenue Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.5.4. MEA revenue Advanced Dermatology Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. AptarGroup, Inc.

9.2.2. Becton, Dickinson and Company

9.2.3. Bespak

9.2.4. Credence MedSystems, Inc.

9.2.5. E3D Elcam Drug Delivery Devices

9.2.6. Kindeva Drug Delivery L.P.

9.2.7. Latch Medical

9.2.8. LTS Lohmann Therapie-Systeme AG

9.2.9. Medicsensors S.L

9.2.10. Midas Pharma GmbH

9.2.11. Nemera

9.2.12. Owen Mumford

9.2.13. Portal Instruments, Inc.

9.2.14. Vaxxas Inc.

9.2.15. West Pharmaceutical Services, Inc.

9.2.16. The 3M Company

9.2.17. Zosano Pharma Corporation

9.2.18. Raphas Co., Ltd.

9.2.19. Nanopass Tech

9.2.20. Corium International, Inc.

9.2.21. Valeritas, Inc.

9.2.22. Nitto Denko Corporation

9.2.23. Microdermics Inc.

9.2.24. TheraJect, Inc.

9.2.25. Endoderma Ltd.

9.2.26. QuadMedicine

9.2.27. SNvia Co., Ltd.

9.2.28. Small Lab

9.2.29. AdminMed nanoBioSciences LLC

9.2.30. BioSerenTach Inc

9.2.31. Innoture Medical Technology Limited

9.2.32. Clearside Biomedical

9.2.33. CosMED Pharmaceutical Co.Ltd.

9.2.34. Mindera Corp

8.3. List of Other Prominent Players

Segmentation of Advanced Dermatology Drug Delivery Devices Market -

By Product-

  • Injectors
    • Disposable Injectors
    • Reusable Injectors
    • Wearable Injectors
  • Patches
    • Microneedle Patches
    • Solid Removable Microneedles
    • Coated Microneedles
    • Dissolving Microneedles
    • Hollow Microneedles
    • Hydrogel Forming Microneedles
    • Needle-Less Patches
  • Dermal Pumps
  • Airless Dispensers and Bottles
  • Valves
  • Other Devices.

By Sales Channel-

  • B2B Sales Channel
  • B2C Sales Channel

By End-Users-

  • Hospitals
  • Dermatology Practices
  • Home Use

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Global Advanced Dermatology Drug Delivery Devices Market?

USD 9.60 Billion by 2030

exhibiting a CAGR of 9.4% during the forecast period

Our Clients